×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Heal... [24]
Institute of Ch... [21]
Authors
LEUNG CHUNG HANG [6]
CHUXIA DENG [6]
QIAN LUO [6]
WANG YITAO [5]
WANG SHENGPENG [5]
CHEN MEIWAN [4]
More...
Document Type
Journal article [44]
Conference paper [4]
Presentation [3]
Project [3]
Other [1]
Date Issued
2023 [1]
2022 [13]
2021 [15]
2020 [4]
2019 [6]
2018 [6]
More...
Language
英語English [43]
Source Publication
Frontiers in Imm... [3]
Genes and Diseas... [3]
Advanced Science [2]
Cancers [2]
Chinese Medicine [2]
Frontiers in Cel... [2]
More...
Indexed By
SCIE [30]
其他 [1]
Funding Organization
Funding Project
Studies on the c... [1]
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 55
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Submit date Ascending
Submit date Descending
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer
Journal article
Journal of Drug Delivery Science and Technology, 2023,Volume: 79,Page: 103922
Authors:
Wang, Yan
;
Zhang, Chen
;
Xiao, Meng
;
Ganesan, Kumar
;
Gao, Fei
;
Liu, Qingqing
;
Ye, Zhen
;
Sui, Yue
;
Zhang, Feng
;
Wei, Kunhua
;
Wu, Yaobin
;
Wu, Jianmin
;
Du, Bing
;
Xu, Cong
;
Li, Yan
;
Li, Peng
;
Zhang, Jinming
;
Chen, Jianping
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2023/02/01
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer
Conference paper
University of Macau, 2022-12-2
Authors:
Xingan Xing
;
Zhiwei Zhou
;
Zheng WH(鄭文華)
Microsoft Word
|
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/12/22
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer
Conference paper
Online, 2022-12-11
Authors:
Xingan Xing
;
Zhiwei Zhou
;
Zheng WH(鄭文華)
Microsoft Word
|
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/12/22
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer
Journal article
Frontiers in Immunology, 2022,Volume: 13
Authors:
Liu, Xinkui
;
Bai, Meirong
;
Li, Huiying
;
Ye, Peizhi
;
Duan, Xiaoxia
;
Wu, Chao
;
Huang, Zhihong
;
Lu, Shan
;
Zhang, Jingyuan
;
Zhao, Zihan
;
Guo, Fengying
;
You, Rongli
;
Qin, Wenjie
;
Wang, Wei
;
Han, Aiqing
;
Shen, Liangliang
;
Wang, Yitao
;
Zhao, Zheng
;
Luo, Hua
;
Wu, Jiarui
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/12/01
4T1 tumor bearing mice
compound kushen injection
single cell RNA-sequencing
T lymphocytes
triple-negative breast cancer
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer.The 8th Macau Symposium on Biomedical Sciences 2022(2022)
Conference paper
University of Macau, 2022-10-14
Authors:
Xingan XING
;
Zheng WH(鄭文華)
Microsoft Word
|
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/12/21
Epigenetics of the Immune Component of Inflammation
Journal article
Frontiers in Immunology, 2022
Authors:
Liu, Yan-Jun
;
Wang, Haitao
;
Zhong, Hai-Jing
;
Chong, Cheong-Meng
;
Yang, Guan-Jun
Favorite
|
|
TC[WOS]:
1
TC[Scopus]:
1
|
Submit date:2022/08/12
Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
Journal article
Frontiers in Oncology, 2022,Volume: 12
Authors:
Wei, Chunli
;
Khan, Md Asaduzzaman
;
Du, Jiaman
;
Cheng, Jingliang
;
Tania, Mousumi
;
Leung, Elaine Lai Han
;
Fu, Junjiang
Favorite
|
|
TC[WOS]:
5
TC[Scopus]:
5
|
Submit date:2023/01/30
cancer therapeutics
cell migration and invasion
cordycepin
Slug
triple-negative breast cancer (TNBC)
Twist1
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin
Journal article
eFood, 2022,Volume: 3,Issue: e3
Authors:
Ruting ZHONG
;
Mohamed A. Farag
;
Meiwan Che
;
Chengwei He
;
Jianbo Xiao
Adobe PDF
|
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/07/29
Bioactivities
Fisetin
Molecular Mechanism
Pharmacokinetics
Structure–activity Relationship
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Journal article
Chinese Medicine, 2022,Volume: 17,Issue: 1
Authors:
Zhang, Shuang
;
Dong, Yu
;
Chen, Xiuping
;
Tan, Chris Soon Heng
;
Li, Min
;
Miao, Kai
;
Lu, Jia Hong
Favorite
|
|
TC[WOS]:
1
TC[Scopus]:
1
|
Submit date:2022/05/31
Apoptosis
Autophagy Inhibition
Irinotecan
Lysosome
Sn-38
Toosendanin
Triple-negative Breast Cancer
FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model
Journal article
Frontiers in Immunology, 2022,Volume: 13
Authors:
Lei, Josh Haipeng
;
Zhang, Lei
;
Wang, Zhenyi
;
Peltier, Raoul
;
Xie, Yusheng
;
Chen, Ganchao
;
Lin, Shiqi
;
Miao, Kai
;
Deng, Chu Xia
;
Sun, Hongyan
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/05/31
BRD4
epigenetic
FGFR2
immunotherapy
posttranslational modifications
TNBC